QIAGEN N.V.

QGEN XNYS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

7.4B

Short interest (May 15)

4.4%

Net Short (Jun 03 ): -0.3%

Borrow Fee

0.36%

↑ 3.4%

Available Shares

600K

↑ 20.0%

Price Chart

Company Overview

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Company Info

Exchange: NYSE

CIK: 0001015820

Asset Type: CS

Market Data

Market Cap: $7,361,062,500

Employees: 5,500

Status: Active

Short Interest

Current Borrow Fee 0.36%

Range: 0.36% - 0.36%

Available Shares 600K

Range: 600K - 600K

Recent Changes

Fee Change: ↓ 12.5%

Available Change: ↓ 10.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime